J2351 Injection ocrelizumab 1mg hya-ocsq
J-Codes
Also known as: ocrelizumab, Hyalogic OCSQ ocrelizumab
Injection of ocrelizumab 1 mg (Hyalogic OCSQ brand). A CD20-targeted monoclonal antibody from specific manufacturer.
Clinical Context
Identical clinical use to standard ocrelizumab for multiple sclerosis. Hyalogic OCSQ is a specific manufacturer formulation.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.